Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.

SA Treepongkaruna - Journal of the Medical Association of Thailand …, 2011 - europepmc.org
Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with
liver masses. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
被引用次数：23 相关文章

[引用][C] Serum AFP and AFP-L3 in Clinically Distinguished Hepatocellular Carcinoma from Patients with Liver Masses

S Subwongcharoen, K Leelawat… - JOURNAL OF THE …, 2011 - jmatonline.com
Serum AFP and AFP-L3 in Clinically Distinguished Hepatocellular Carcinoma from Patients
with Liver Masses | Subwongcharoen | JOURNAL OF THE MEDICAL ASSOCIATION OF …

Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses

S Subwongcharoen, K Leelawat… - Journal of the …, 2011 - pubmed.ncbi.nlm.nih.gov
Objective To determine the ability of alpha fetoprotein (AFP) and AFP-L3% serum level in
discriminating hepatocellular carcinoma (HCC) from other types of liver mass. Material and …